Oyster Point Pharma Inc

Oyster Point Pharma Inc

OYST - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$299.7M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Oyster Point Pharma IncOyster Point Pharma Inc-2.8-851%--4.3
$18.60

Current Fair Value

66.5% upside

Undervalued by 66.5% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$299.70 Million
Enterprise Value$325.62 Million
Earnings per Share$-4.01
Beta0
Outstanding Shares26,830,756

Return

Return on Equity851.15%ROE
Return on Assets-173.05%
Return on Invested Capital-205.39%

Valuation & Multiples

P/E Ratio-2.79P/E Ratio
PEG-2.18PEG
Price to Sales-Price to Sales
Price to Book Ratio-11.17Price to Book Ratio
Enterprise Value to Revenue16.63
Enterprise Value to EBIT-1.98
Enterprise Value to Net Income-2
Total Debt to Enterprise0.29
Debt to Equity-4.27Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Oyster Point Pharma Inc

Oyster Point Pharma Insider Information FAQ

In the latest 13F quarter on Stockcircle, 3 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.